Coronavirus Disease 2019 Vaccine Development: An Overview

被引：16

作者：

Sumirtanurdin, Riyadi ^{[1
,2
]}

Barliana, Melisa Intan ^{[2
,3
]}

机构：

[1] Univ Padjadjaran, Fac Pharm, Educ, Bandung, Indonesia

[2] Univ Padjadjaran, Dept Biol Pharm, Biotechnol Pharm Lab, Fac Pharm, Bandung, Indonesia

[3] Univ Padjadjaran, Ctr Excellence Higher Educ Pharmaceut Care Innova, Bandung, Indonesia

来源：

VIRAL IMMUNOLOGY | 2021年 / 34卷 / 03期

关键词：

SARS-CoV-2; challenges; platforms; progress; RECEPTOR-BINDING DOMAIN; DENDRITIC CELLS; VIRAL VECTORS; VIRUS; PARTICLES;

D O I：

10.1089/vim.2020.0119

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

To this day, the coronavirus disease 2019 (COVID-19) pandemic has not shown signs of abating. Moreover, the virus responsible for the pandemic, severe acute respiratory syndrome coronavirus 2, has evolved into three different variants. This phenomenon highlights an even greater need to develop drugs and vaccines to control the rate of infection and spread of the disease. As of July 7, 2020, at least 160 vaccine candidates, 21 of which have entered the clinical trial phase, have been developed. This article describes the latest advances in development, reliable platforms, strategies used, and challenges that remain in developing COVID-19 vaccines.

引用

页码：134 / 144

页数：11

共 50 条

[21] Updates on the coronavirus disease 2019 vaccine and consideration in children
Kang, Hyun Mi
Choi, Eun Hwa
Kim, Yae-Jean
CLINICAL AND EXPERIMENTAL PEDIATRICS, 2021, 64 (07) : 328 - 338
[22] Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development
Ezzikouri, Sayeh
Nourlil, Jalal
Benjelloun, Soumaya
Kohara, Michinori
Tsukiyama-Kohara, Kyoko
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (12) : 2992 - 3000
[23] Coronavirus disease 2019: fundamentals, chronology and vaccine evolution
Thirupathaiah, Yeruva
Chandel, Anuj Kumar
REVIEWS IN MEDICAL MICROBIOLOGY, 2021, 32 (04) : 246 - 254
[24] „Coronavirus disease 2019“Coronavirus disease 2019
Reinhold Kerbl
Fred Zepp
Monatsschrift Kinderheilkunde, 2021, 169 (4) : 308 - 311
[25] Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease
Sparks, Jeffrey A.
Wallace, Zachary S.
Robinson, Philip C.
CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (05) : 412 - 418
[26] Graded coronavirus disease 2019 vaccine administration A safe alternative to vaccine avoidance
Pitlick, Mitchell M.
Gonzalez-Estrada, Alexei
Park, Miguel A.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 128 (06) : 731 - 733
[27] An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19)
Pagliano, Pasquale
Sellitto, Carmine
Scarpati, Giuliana
Ascione, Tiziana
Conti, Valeria
Franci, Gianluigi
Piazza, Ornella
Filippelli, Amelia
EXPERT OPINION ON DRUG DISCOVERY, 2022, 17 (01) : 9 - 18
[28] Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)
Bennet, Bindu M.
Wolf, Jayanthi
Laureano, Rodrigo
Sellers, Rani S.
TOXICOLOGIC PATHOLOGY, 2020, 48 (07) : 800 - 809
[29] An overview of the effect of bioaerosol size in coronavirus disease 2019 transmission
Guzman, Marcelo I.
INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2021, 36 (02): : 257 - 266
[30] Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic
Lui, Rashid N.
Wong, Sunny H.
Sanchez-Luna, Sergio A.
Pellino, Gianluca
Bollipo, Steven
Wong, Mei-Yin
Chiu, Philip W. Y.
Sung, Joseph J. Y.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (05) : 749 - 759

← 1 2 3 4 5 →